RT Journal Article T1 High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study. A1 Carretero-Gomez, Juana A1 Perez-Martinez, Pablo A1 Segui-Ripoll, Jose Miguel A1 Carrasco-Sanchez, Francisco Javier A1 Lois Martinez, Nagore A1 Fernandez Perez, Esther A1 Perez Hernandez, Onan A1 Garcia Ordoñez, Miguel Angel A1 Martin Gonzalez, Candelaria A1 Vigueras-Perez, Juan Francisco A1 Puchades, Francesc A1 Blasco Avaria, Maria Cristina A1 Perez Soto, Maria Isabel A1 Ena, Javier A1 Arevalo-Lorido, Jose Carlos K1 Adiposity K1 Inflammation K1 Obesity K1 Phenotypes K1 Waist circumference K1 Área de Gestión Sanitaria Norte de Málaga AB Background: Describe the profile of patients with obesity in internal medicine to determine the role of adiposity and related inflammation on the metabolic risk profile and, identify various “high-risk obesity” phenotypes by means of a cluster analysis. This study aimed to identify different profiles of patients with high-risk obesity based on a cluster analysis. Methods: Cross-sectional, multicenter project that included outpatients attended to in internal medicine. A total of 536 patients were studied. The mean age was 62 years, 51% were women. Patients were recruited from internal medicine departments over two weeks in November and December 2021 and classified into four risk groups according to body mass index (BMI) and waist circumference (WC). High-risk obesity was defined as BMI > 35 Kg/m2 or BMI 30−34.9 Kg/m2 and a high WC (>102 cm for men and >88 cm for women). Hierarchical and partitioning clustering approaches were performed to identify profiles. Results: A total of 462 (86%) subjects were classified into the high-risk obesity group. After excluding 19 patients missing critical data, two profiles emerged: cluster 1 (n = 396) and cluster 2 (n = 47). Compared to cluster 1, cluster 2 had a worse profile, characterized by older age (77 ± 16 vs. 61 ± 21 years, p 35 Kg/m2 or BMI 30−34.9 Kg/m2 and a high WC (>102 cm for men and >88 cm for women). Hierarchical and partitioning clustering approaches were performed to identify profiles. Results: A total of 462 (86%) subjects were classified into the high-risk obesity group. After excluding 19 patients missing critical data, two profiles emerged: cluster 1 (n = 396) and cluster 2 (n = 47). Compared to cluster 1, cluster 2 had a worse profile, characterized by older age (77 ± 16 vs. 61 ± 21 years, p 102 cm for men and >88 cm for women). Hierarchical and partitioning clustering approaches were performed to identify profiles. Results: A total of 462 (86%) subjects were classified into the high-risk obesity group. After excluding 19 patients missing critical data, two profiles emerged: cluster 1 (n = 396) and cluster 2 (n = 47). Compared to cluster 1, cluster 2 had a worse profile, characterized by older age (77 ± 16 vs. 61 ± 21 years, p 88 cm for women). Hierarchical and partitioning clustering approaches were performed to identify profiles. Results: A total of 462 (86%) subjects were classified into the high-risk obesity group. After excluding 19 patients missing critical data, two profiles emerged: cluster 1 (n = 396) and cluster 2 (n = 47). Compared to cluster 1, cluster 2 had a worse profile, characterized by older age (77 ± 16 vs. 61 ± 21 years, p 3 (53% vs. 5%, p< 0.001), depression (36% vs. 19%, p = 0.008), severe disability(64% vs. 3%, p < 0.001), and a sarcopenia score ≥ 4 (79% vs. 16%, p < 0.01). In addition, cluster 2 had greater inflammation than cluster 1 (hsCRP: 5.8 ± 4.1 vs. 2.1 ± 4.5 mg/dL, p = 0.008). Conclusions: Two profiles of subjects with high-risk obesity were identified. Based on that, older subjects with obesityrequire measures that target sarcopenia, disability, psychological health, and significant comorbidities to prevent further health deterioration. Longitudinal studies should be performed to identify potential risk factors of subjects who progress from cluster 1 to cluster 2. PB MDPI SN 2077-0383 YR 2022 FD 2022-08-02 LK http://hdl.handle.net/10668/21332 UL http://hdl.handle.net/10668/21332 LA en NO Carretero-Gómez J, Pérez-Martínez P, Seguí-Ripoll JM, Carrasco-Sánchez FJ, Lois Martínez N, Fernández Pérez E, et al. High-Risk Obesity Phenotypes: Target for Multimorbidity Prevention at the ROFEMI Study. J Clin Med. 2022 Aug 9;11(16):4644 DS RISalud RD Apr 6, 2025